Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Pyne

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Pharmacology|January 7, 2016
Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2Robert J Slack, Maryam Hafeji, Rebecca Rogers, et al.
Cellular Signalling|June 24, 2010
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsFrancesca Tonelli, Keng Gat Lim, Carolyn Loveridge, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Cellular Signalling|January 15, 2013
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cellsDavid G Watson, Francesca Tonelli, Manal Alossaimi, et al.
Cellular Signalling|December 10, 2020
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosisStephanie Schwalm, Sandra Beyer, Redona Hafizi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2005
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1Catherine M Waters, Jaclyn Long, Irina Gorshkova, et al.
International Journal of Molecular Sciences|November 11, 2020
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T LymphocytesSun-Hye Shin, Hee-Yeon Kim, Hee-Soo Yoon, et al.
Journal of Medicinal Chemistry|March 20, 2019
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2David R Adams, Salha Tawati, Giacomo Berretta, et al.
Plos One|February 10, 2011
Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyaseEvgeny V Berdyshev, Irina Gorshkova, Peter Usatyuk, et al.
The Journal of Biological Chemistry|April 18, 2021
A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cellsRyan D R Brown, Ben E P Veerman, Jeongah Oh, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Pharmacology|January 7, 2016
Pharmacological Characterization of the αvβ6 Integrin Binding and Internalization Kinetics of the Foot-and-Mouth Disease Virus Derived Peptide A20FMDV2Robert J Slack, Maryam Hafeji, Rebecca Rogers, et al.
Cellular Signalling|June 24, 2010
FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsFrancesca Tonelli, Keng Gat Lim, Carolyn Loveridge, et al.
The American Journal of Pathology|October 5, 2010
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patientsCarol Watson, Jaclyn S Long, Clare Orange, et al.
Cellular Signalling|January 15, 2013
The roles of sphingosine kinases 1 and 2 in regulating the Warburg effect in prostate cancer cellsDavid G Watson, Francesca Tonelli, Manal Alossaimi, et al.
Cellular Signalling|December 10, 2020
Validation of highly selective sphingosine kinase 2 inhibitors SLM6031434 and HWG-35D as effective anti-fibrotic treatment options in a mouse model of tubulointerstitial fibrosisStephanie Schwalm, Sandra Beyer, Redona Hafizi, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|December 2, 2005
Cell migration activated by platelet-derived growth factor receptor is blocked by an inverse agonist of the sphingosine 1-phosphate receptor-1Catherine M Waters, Jaclyn Long, Irina Gorshkova, et al.
International Journal of Molecular Sciences|November 11, 2020
A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T LymphocytesSun-Hye Shin, Hee-Yeon Kim, Hee-Soo Yoon, et al.
Journal of Medicinal Chemistry|March 20, 2019
Topographical Mapping of Isoform-Selectivity Determinants for J-Channel-Binding Inhibitors of Sphingosine Kinases 1 and 2David R Adams, Salha Tawati, Giacomo Berretta, et al.
Plos One|February 10, 2011
Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyaseEvgeny V Berdyshev, Irina Gorshkova, Peter Usatyuk, et al.
The Journal of Biological Chemistry|April 18, 2021
A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cellsRyan D R Brown, Ben E P Veerman, Jeongah Oh, et al.
Pageof 10